Metabotropic glutamate receptors: targets for therapy of cerebral ischaemia

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Expert opinion on therapeutic targets

• Publication date

  2001-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1517/14728222.5.6.669PMID 12540277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia.

  2001influential reference
• (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord.

  2001cited by this paper
• Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer

  2001cited by this paper
• Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain.

  2001cited by this paper
• BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity.

  2001cited by this paper
• Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission.

  2001cited by this paper
• An activity‐dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors

  2001cited by this paper
• Metabotropic Glutamate Receptor Subtypes 1 and 5 Are Activators of Extracellular Signal-Regulated Kinase Signaling Required for Inflammatory Pain in Mice

  2001cited by this paper
• Localization of the human mGluR4 gene within an epilepsy susceptibility locus(1).

  2001cited by this paper
• Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGlu5 dimerization.

  2001cited by this paper
• Design of NAALADase inhibitors: a novel neuroprotective strategy.

  2001cited by this paper
• Knockdown of spinal metabotropic glutamate receptor 1 (mGluR1) alleviates pain and restores opioid efficacy after nerve injury in rats

  2001cited by this paper
• Exacerbation of neuronal cell death by activation of group I metabotropic glutamate receptors: role of NMDA receptors and arachidonic acid release.

  2001cited by this paper
• Homology model of the closed, functionally active, form of the amino terminal domain of mGlur1.

  2001cited by this paper
• Peripheral group I metabotropic glutamate receptors modulate nociception in mice

  2001cited by this paper
• Medical therapy for acute ischemic stroke

  2001cited by this paper
• Elevated levels of group‐III metabotropic glutamate receptors in the inferior colliculus of genetically epilepsy‐prone rats following intracollicular administration of l‐serine‐O‐phosphate

  2001cited by this paper
• Molecular determinants of metabotropic glutamate receptor signaling.

  2001cited by this paper
• The mGlu(2/3) agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate, is anti- and proconvulsant in DBA/2 mice.

  2001cited by this paper
• Three‐dimensional model of the extracellular domain of the type 4a metabotropic glutamate receptor: New insights into the activation process

  2000cited by this paper
• Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor

  2000cited by this paper
• Neuroprotection against hypoxic/hypoglycaemic injury after the insult by the group III metabotropic glutamate receptor agonist (R,S)‐4‐phosphonophenylglycine

  2000cited by this paper
• Pharmacological characterization of the rat metabotropic glutamate receptor type 8a revealed strong similarities and slight differences with the type 4a receptor.

  2000cited by this paper
• (+)-4-phosphonophenylglycine (PPG) a new group III selective metabotropic glutamate receptor agonist.

  2000cited by this paper
• The role of Arg(78) in the metabotropic glutamate receptor mGlu(1) for agonist binding and selectivity.

  2000cited by this paper
• N-acetylaspartylglutamate protects against transient focal cerebral ischemia in rats.

  2000cited by this paper
• Involvement of mGluR(5) on acute nociceptive transmission.

  2000cited by this paper
• Synthesis, molecular modeling and preliminary biological evaluation of 1-amino-3-phosphono-3-cyclopentene-1-carboxylic acid and 1-amino-3-phosphono-2-cyclopentene-1-carboxylic acid, two novel agonists of metabotropic glutamate receptors of group III.

  2000cited by this paper
• Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo.

  2000cited by this paper
• Up‐regulation of the metabotropic glutamate receptor mGluR4 in hippocampal neurons with reduced seizure vulnerability

  2000cited by this paper
• Brain ischemia and reperfusion: molecular mechanisms of neuronal injury.

  2000cited by this paper
• The Non-competitive Antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the Transmembrane Region of Group I Metabotropic Glutamate Receptors*

  2000cited by this paper
• Molecular mechanisms of ischemic neuronal injury.

  2000cited by this paper
• Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil.

  2000cited by this paper
• Selective Activation of mGlu4 Metabotropic Glutamate Receptors Is Protective against Excitotoxic Neuronal Death

  2000cited by this paper
• Chiral resolution, pharmacological characterization, and receptor docking of the noncompetitive mGlu1 receptor antagonist (+/-)-2-hydroxyimino- 1a, 2-dihydro-1H-7-oxacyclopropa[b]naphthalene-7a-carboxylic acid ethyl ester.

  2000cited by this paper
• Mutagenesis and Modeling of the GABAB Receptor Extracellular Domain Support a Venus Flytrap Mechanism for Ligand Binding*

  1999cited by this paper
• Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795.

  1999cited by this paper
• Molecular tinkering of G protein‐coupled receptors: an evolutionary success

  1999cited by this paper
• Pathobiology of ischaemic stroke: an integrated view.

  1999cited by this paper
• 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.

  1999cited by this paper
• SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5.

  1999cited by this paper
• Pharmacophore models of group I and group II metabotropic glutamate receptor agonists. Analysis of conformational, steric, and topological parameters affecting potency and selectivity.

  1999cited by this paper
• Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: a different environment but similar recognition of an extended glutamate conformation.

  1999cited by this paper
• Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors.

  1999cited by this paper
• 1‐Aminoindan‐1,5‐dicarboxylic acid and (S)‐(+)‐2‐(3′‐carboxybicyclo[1.1.1] pentyl)‐glycine, two mGlu1 receptor‐preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia

  1999cited by this paper
• LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia.

  1999cited by this paper
• Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.

  1999cited by this paper
• Extended glutamate activates metabotropic receptor types 1, 2 and 4: selective features at mGluR4 binding site.

  1999cited by this paper
• Neuroprotection in Acute Ischaemic Stroke

  1999cited by this paper
• Neuroprotective Actions of Novel and Potent Ligands of Group I and Group II Metabotropic Glutamate Receptors

  1999cited by this paper
• Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury

  1999cited by this paper
• Modeling of amino-terminal domains of group I metabotropic glutamate receptors: structural motifs affecting ligand selectivity.

  1999cited by this paper
• Reversal of glutamate excitotoxicity by activation of PKC‐associated metabotropic glutamate receptors in cerebellar granule cells relies on NR2C subunit expression

  1999cited by this paper
• Antagonist pharmacology of metabotropic glutamate receptors coupled to phospholipase D activation in adult rat hippocampus: focus on (2R,1'S,2'R,3'S)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine versus 3, 5-dihydroxyphenylglycine.

  1999cited by this paper
• CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding.

  1999cited by this paper
• Probing the Ligand-binding Domain of the mGluR4 Subtype of Metabotropic Glutamate Receptor*

  1999cited by this paper
• Evidence for Metabotropic Glutamate Receptor Activation in the Induction of Depolarization-Induced Suppression of Inhibition in Hippocampal CA1

  1998cited by this paper
• 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution.

  1998cited by this paper
• Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist.

  1998cited by this paper
• Altered spatial learning and memory in mice lacking the mGluR4 subtype of metabotropic glutamate receptor.

  1998cited by this paper
• Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.

  1998cited by this paper
• Neuroprotective effects of a systemically active Group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia

  1998cited by this paper
• Antagonists for group I mGluRs attenuate excitotoxic neuronal death in cortical cultures

  1998cited by this paper
• Neuroprotection by Glial Metabotropic Glutamate Receptors Is Mediated by Transforming Growth Factor-β

  1998cited by this paper
• Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors.

  1998cited by this paper
• Expression and Purification of the Extracellular Ligand Binding Region of Metabotropic Glutamate Receptor Subtype 1*

  1998influential reference
• Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia.

  1998influential reference
• Localization of a metabotropic glutamate receptor, mGluR7, in axon terminals of presumed nociceptive, primary afferent fibers in the superficial layers of the spinal dorsal horn: an electron microscope study in the rat.

  1997cited by this paper
• Type 2 Metabotropic Glutamate (mGlu) Receptors Tonically Inhibit Transmitter Release in Rat Caudate Nucleus: In Vivo Studies with (2S,1′S,2′S,3′R)‐2‐(2′‐carboxy‐3′‐phenylcyclopropyl)glycine, a New Potent and Selective Antagonist

  1997cited by this paper
• Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties.

  1997cited by this paper
• (+)-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors

  1997cited by this paper
• Pharmacology and functions of metabotropic glutamate receptors.

  1997cited by this paper
• (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus.

  1997cited by this paper
• Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes.

  1997cited by this paper
• Evidence against a permissive role of the metabotropic glutamate receptor 1 in acute excitotoxicity.

  1997cited by this paper
• Homology modeling of metabotropic glutamate receptors. (mGluRs) structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonists.

  1996cited by this paper
• Cloning and Functional Expression of a DrosophilaMetabotropic Glutamate Receptor Expressed in the Embryonic CNS

  1996cited by this paper
• The effects of (RS)‐α‐cyclopropyl‐4‐phosphonophenylglycine ((RS)‐CPPG), a potent and selective metabotropic glutamate receptor antagonist

  1996cited by this paper
• Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?

  1996cited by this paper
• Functional coupling between ryanodine receptors and L-type calcium channels in neurons

  1996cited by this paper
• Activation of group III metabotropic glutamate receptors is neuroprotective in cortical cultures.

  1996cited by this paper
• Metabotropic Glutamate Receptor 5 Is a Disulfide-linked Dimer*

  1996cited by this paper
• Synthesis and pharmacological characterization of all sixteen stereoisomers of 2-(2'-carboxy-3'-phenylcyclopropyl)glycine. Focus on (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a novel and selective group II metabotropic glutamate receptors antagonist.

  1996cited by this paper
• (S)-(+)-2-(3'-carboxybicyclo[1.1.1]pentyl)-glycine, a structurally new group I metabotropic glutamate receptor antagonist.

  1996cited by this paper
• Calcium: still center-stage in hypoxic-ischemic neuronal death

  1995cited by this paper
• 1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors.

  1995cited by this paper
• Antibodies inactivating mGluR1 metabotropic glutamate receptor block long-term depression in cultured Purkinje cells.

  1994cited by this paper
• The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins.

  1993cited by this paper
• N‐Acetylaspartylglutamate Inhibits Forskolin‐Stimulated Cyclic AMP Levels via a Metabotropic Glutamate Receptor in Cultured Cerebellar Granule Cells

  1993cited by this paper
• Definition of a pharmacophore for the metabotropic glutamate receptors negatively linked to adenylyl cyclase.

  1993cited by this paper
• A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord

  1993cited by this paper
• Role of the large extracellular domain of metabotropic glutamate receptors in agonist selectivity determination.

  1993influential reference
• Competitive antagonism at metabotropic glutamate receptors by (S)-4-carboxyphenylglycine and (RS)-alpha-methyl-4-carboxyphenylglycine.

  1993cited by this paper
• Metabotropic Excitatory Amino Acid Receptor Activation Stimulates Phospholipase D in Hippocampal Slices

  1992cited by this paper
• Molecular diversity of glutamate receptors and implications for brain function.

  1992cited by this paper
• Sequence and expression of a metabotropic glutamate receptor

  1991cited by this paper

• Chiral ligand-exchange separation and resolution of extremely rigid glutamate analogs: 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids

  2010cites this paper
• Synthesis and Preliminary Biological Evaluation of 2′‐Substituted 2‐(3′‐Carboxybicyclo[1.1.1]pentyl)glycine Derivatives as Group I Selective Metabotropic Glutamate Receptor Ligands

  2006cites this paper
• Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.

  2006cites this paper
• Stereoselective synthesis and preliminary evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): identification of (+)-3-MATIDA as a novel mGluR1 competitive antagonist.

  2004cites this paper
• The role of electrostatic interaction in the molecular recognition of selective agonists to metabotropic glutamate receptors

  2003cites this paper
• Molecular dynamics simulation of the ligand binding domain of mGluR1 in response to agonist and antagonist binding

  2002cites this paper